Cargando…
Spotlight on elotuzumab in the treatment of multiple myeloma: the evidence to date
Despite advances in the treatment of multiple myeloma, it remains an incurable disease, with relapses and resistances frequently observed. Recently, immunotherapies, in particular, monoclonal antibodies, have become important treatment options in anticancer therapies. Elotuzumab is a humanized monoc...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063562/ https://www.ncbi.nlm.nih.gov/pubmed/27785050 http://dx.doi.org/10.2147/OTT.S94531 |